Source: The Hematology Journal. Conference titles: Annual Meeting of the European Hematology Association. Unidade: FMRP
Subjects: INFARTO DO MIOCÁRDIO, HEMATOLOGIA
ABNT
FRANCO, Rendrik França et al. Gene polymorphisms in the thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of myocardial infarction. The Hematology Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 19 out. 2024. , 2002APA
Franco, R. F., Meijers, J. C. M., Pazin-Filho, A., Simões, M. V., Marin-Neto, J. A., Tavella, M. H., et al. (2002). Gene polymorphisms in the thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of myocardial infarction. The Hematology Journal. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Franco RF, Meijers JCM, Pazin-Filho A, Simões MV, Marin-Neto JA, Tavella MH, Araújo AG, Reitsma PH, Zago MA. Gene polymorphisms in the thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of myocardial infarction. The Hematology Journal. 2002 ; 3 102 res. 0321.[citado 2024 out. 19 ]Vancouver
Franco RF, Meijers JCM, Pazin-Filho A, Simões MV, Marin-Neto JA, Tavella MH, Araújo AG, Reitsma PH, Zago MA. Gene polymorphisms in the thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of myocardial infarction. The Hematology Journal. 2002 ; 3 102 res. 0321.[citado 2024 out. 19 ]